Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Charles C. Weise"'
Autor:
Eugene A. DuBoff, Robert Wolkow, Ward T. Smith, Donald England, Murray Rosenthal, Charles C. Weise, Peter D. Londborg, James Ferguson
Publikováno v:
The British journal of psychiatry : the journal of mental science. 173
BackgroundThis study compared the efficacy and safety of sertraline to placebo in treating panic disorder.Method178 out-patients with panic disorder who exhibited at least four panic attacks during the four weeks prior to screening and three during t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db3fb989282c75c2b728ab2824547523
https://pubmed.ncbi.nlm.nih.gov/9850204
https://pubmed.ncbi.nlm.nih.gov/9850204
Publikováno v:
Journal of Clinical Psychopharmacology. 11:233
Results are presented of the first double-blind, placebo-controlled trial of a novel antidepressant venlafaxine, which preclinically has demonstrated serotonin, norepinephrine, and dopamine reuptake inhibiting effects. Sixty outpatients meeting DSM-I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47cb53c3badc360de8cff62012acd7ff
https://doi.org/10.1097/00004714-199108000-00002
https://doi.org/10.1097/00004714-199108000-00002
Publikováno v:
Acta Psychiatrica Scandinavica. 80:117-123
A placebo-controlled, randomized, double-blind study was carried out in outpatients suffering from major unipolar depressive disorder to assess the efficacy and tolerability of paroxetine in the treatment of depression. The study lasted for six weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97fc40a5d529bc0ab945de34334efc33
https://doi.org/10.1111/j.1600-0447.1989.tb07188.x
https://doi.org/10.1111/j.1600-0447.1989.tb07188.x
Autor:
Hack R. Chung, Howard Rosenfeld, Karl Rickels, Harold S. Feldman, Edward M. Whalen, Irma Csanalosi, Charles C. Weise
Publikováno v:
Psychopharmacologia. 34:361-376
Clomipramine (75–125 mg/day), a relatively new tricyclic anti-depressant, was compared to amitriptyline (75–125 mg/day) in a double-blind 6 week trial carried out with 93 psychiatric and 75 non-psychiatric depressed out patients. Psychiatric pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e639628f67690e280cce43e96ffb7d41
https://doi.org/10.1007/bf00422559
https://doi.org/10.1007/bf00422559
Publikováno v:
Psychopharmacology. 80:14-18
Seventy-four patients were treated with 150 mg/day amitriptyline (AT) to determine possible correlations between clinical improvement, demographic variables, and AT and nortriptyline (NT) plasma levels. Plasma level determinations after 2 and 6 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf29947ff18bc43451b95aecbefdf82
https://doi.org/10.1007/bf00427486
https://doi.org/10.1007/bf00427486
Publikováno v:
Acta Psychiatrica Scandinavica. 66:109-120
This is a double-blind study involving 158 outpatients diagnosed ac-cording to the DSM-III as suffering from major depressive disorder. Both active drugs produced significantly more improvement than placebo on both physician and patient ratings, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed16dcb6d65b75cb02262090f2ff8c1a
https://doi.org/10.1111/j.1600-0447.1982.tb00919.x
https://doi.org/10.1111/j.1600-0447.1982.tb00919.x
Publikováno v:
British Journal of Psychiatry. 125:79-87
A total of 155 anxious neurotic out-patients participated in this double-blind drug trial of thiothixene, thioridazine, and placebo. Ninety-six patients completed at least four weeks of treatment. Thioridazine produced the most and placebo the least
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce5917753b9e64bf56db2b3dcbb9c6f8
https://doi.org/10.1192/bjp.125.1.79
https://doi.org/10.1192/bjp.125.1.79
Publikováno v:
Journal of International Medical Research. 6:180-185
The authors describe a double-blind trial of six weeks duration which was designed to compare the anxiolytic properties of chlordiazepoxide, loxapine and placebo in a total of 135 anxious neurotic out-patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61617d5bb42bc56ede271fa42e4229d9
https://doi.org/10.1177/030006057800600303
https://doi.org/10.1177/030006057800600303
Publikováno v:
Progress in Neuro-Psychopharmacology. 2:191-196
1. 1. Sixty-five anxious neurotic outpatients entered a four week double-blind study comparing chlorpromazine, a phenothiazine, with placebo. 2. 2. Results showed chlorpromazine to produce statistically significant improvement over placebo at treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72f55f4b6fb6a8aafb4d0e2ee6d10584
https://doi.org/10.1016/0364-7722(78)90065-6
https://doi.org/10.1016/0364-7722(78)90065-6
Autor:
Daniel A. Wilson, Harold S. Feldman, Paul E. Gordon, Charles C. Weise, Stanford E. Bazilian, Karl Rickels
Publikováno v:
American Journal of Psychiatry. 127:208-218
In a double-blind controlled study of 122 patients from four populations, amitriptyline produced the most and placebo the least amount of symptomatic improvement, with trimipramine slightly less efficacious than amitriptyline; general practice patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660dfa11af339e61fc14b8e6dab5e942
https://doi.org/10.1176/ajp.127.2.208
https://doi.org/10.1176/ajp.127.2.208